The Effects of Methylene Blue on Hemodynamic Parameters and Cytokine Levels in Refractory Septic Shock.
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : Endogenous nitric oxide (NO) induces the peripheral vasodilation via the activation of guanylate cyclase in patients with septic shock. The purpose of this study was to assess the acute effects of methylene blue (MB), which is an inhibitor of guanylate cyclase, on the hemodynamics and on the production of pro-inflammatory cytokines and nitric oxide (NO) in patients with refractory septic shock. Methods : Twenty consecutive patients with refractory septic shock, which was defined as shock refractory to a dopamine infusion of more than 20 μg/kg/min with the appropriate use of antibiotics and adequate volume replacement, received MB infusion of 1 mg/kg intravenously. The hemodynamic and respiratory variables were measured at baseline, 30, 60 and 120 min after an infusion of MB (1 mg/kg). The blood levels of NO, IL-1, IL-10 and TNF-α were measured at baseline, 30 and 120 min after MB infusion. Results : The administration of MB induced an increase in the systemic vascular resistance (SVR) that resulted in an increase of the mean arterial pressure (MAP) in patients with refractory septic shock, and this was without a decrease in cardiac output. The administered MB induced an increase in pulmonary vascular resistance (PVR) that resulted in an increase of pulmonary arterial pressure (PAP), without any deterioration of gas exchange. However, the increases in SVR and PVR were not associated with the alteration of endogenous production of NO, IL-1, IL-10 and TNF-α. Conclusion : MB transiently elevated the MAP by increasing the SVR without altering the endogenous productions of NO, IL-1, IL-10 and TNF-α during the study period in patients with refractory septic shock.
참고문헌 (37)
- "The pathogenesis of sepsis", 115, pp.457~469 (1991)
- "Methylene blue increases myocardial function in septic shock", 23, pp.1363~1370 (1995)
- "The role of nitric oxide in sepsis and ARDS synopsis of a roundtable conference held in Brussels on 18-20 March 1995", 22, pp.158~165 (1996)
- "Nitric oxide in the pathogenesis of sepsis", 13, pp.449~463 (1999)
- "Role of nitric oxide in the hemodynamic changes of sepsis", 21, pp.759~767 (1993)
- "Nitric oxide and septic shock", 275, pp.1192~1196 (1996)
- "The discovery of endotheilium-derived relaxing factor and its importance in the definition of nitric oxide", 276, pp.1186~1188 (1996)
- "Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis", 120, pp.771~783 (1994)
- "Signal transduction using nitric oxide and cyclic guanosine monophosphate", 276, pp.1189~1192 (1996)
- "Methylene blue administration in septic shock a clinical trial", 23, pp.259~264 (1995)
- "Effect of methylene blue on refractory neonatal hypotension", 129, pp.904~908 (1996)
- "Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock", 21, pp.1027~1031 (1995)
- "Use of methylne blue in patients with refractory septic shock impact on hemodynamics and gas exchange", 13(j), pp.164~168 (1998)
- "Methylene blue increases systemic vascular resistance in human septic shock", 18, pp.309~311 (1992)
- "Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock", 23, pp.1711~1721 (1995)
- "Infusion of methylene blue in human septic shock a pilot, randomized, controlled study.", 29, pp.1860~1867 (2001)
- "Continuous infusion of methylene blue for septic shock", 72, pp.612~614 (1996)
- "Methylene blue reverses endotoxin-induced hypotension", 74, pp.1121~1125 (1994)
- "Inhibition of nitric oxide synthesis by methylene blue", 45, pp.367~374 (1993)
- "Nitric oxide blocks nuclear factor - B activation in alveolar macrophages", 21, pp.311~316 (1999)
- "Nitric oxide regulates endotoxin-induced TNF- production by human neutrophils", 152, pp.4102~4109 (1994)
- "Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells", 196, pp.494~501 (1993)
- "Effects of methylene blue on blood pressure and reactivity to norepinephrine in endotoxemic rats", 21, pp.926~930 (1993)
- "Sepsis and cytokines current status", 77, pp.110~117 (1996)
- "Cyclic GMP and guanylate cyclase mediate lipopolysaccharide-induced Kupffer cell tumor necrosis factor- sysnthesis", 57, pp.297~302 (1995)
- "The influence of methylene blue infusion on cytokine levels during severe sepsis", 30, pp.755~762 (2002)
- "Detection of circulating tumor necrosis factor after endotoxin administration", 318, pp.1481~1486 (1988)
- "Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever", 161, pp.79~84 (1990)
- "The cardiovascular response of normal humans to the administration of endotoxin", 321, pp.280~287 (1989)
- Evgenov OV, "Methylene reduces lung fluid filtration during the early phase of endotoxemia in awake sheep", 29, pp.374~379 (2001)
- "Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells", 97, pp.51~56 (1989)
- "Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the generation of superoxide anion", 254, pp.872~876 (1990)
- "Methylene blue inhibits nitrovasodilator-and endotheilium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion", 263, pp.170~179 (1992)
- "Methylene blue: a promising treatment modality in sepsis induced by bowel perforation", 29, pp.390~395 (1997)
- "Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta", 232, pp.708~716 (1985)
- "Interleukin-1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle", 259 (1990)
- "Methylene blue infusion in septic shock", 23, pp.1935~1936 (1995)
